Amanda Sailliez, PA
Physician Assistant · Murphysboro, ILNPI 1255305967
Payments from drug & device makers
Across 331 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$961
- AstraZeneca$747
- AbbVie$738
- GSK$343
- Amgen$270
- Boehringer Ingelheim$254
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,570100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 54 | $961 |
| AstraZeneca | 47 | $747 |
| AbbVie | 46 | $738 |
| GSK | 23 | $343 |
| Amgen | 18 | $270 |
| Boehringer Ingelheim | 15 | $254 |
| Pfizer | 10 | $182 |
| Sumitomo Pharma America, Inc. | 11 | $181 |
| Abbott | 10 | $172 |
| Novo Nordisk | 10 | $171 |
| Novartis | 9 | $164 |
| Astellas Pharma US Inc | 11 | $161 |
| Merck | 9 | $154 |
| Bayer | 6 | $121 |
| Nestle Healthcare Nutrition Inc. | 6 | $109 |
| Neurocrine Biosciences, Inc. | 5 | $108 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Dexcom, Inc. | 4 | $85 |
| Aimmune Therapeutics, Inc. | 4 | $71 |
| Idorsia Pharmaceuticals US Inc | 4 | $57 |
| Sunovion Pharmaceuticals Inc. | 4 | $56 |
| Johnson & Johnson | 3 | $54 |
| Radius Health, Inc. | 2 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Viatris Specialty LLC | 2 | $38 |
| Exact Sciences | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
How this compares
$5,570 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 77 | $91,147 |
| EliquisApixaban | 107 | $86,398 |
| MounjaroTirzepatide | 72 | $81,743 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 70 | $62,667 |
| FarxigaDapagliflozin Propanediol | 45 | $51,420 |
| TrulicityDulaglutide | 27 | $33,084 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $25,617 |
| JanuviaSitagliptin Phosphate | 25 | $23,093 |
| OzempicSemaglutide | 21 | $20,524 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 23 | $19,701 |
| BelsomraSuvorexant | 19 | $11,930 |
| GemtesaVibegron | 17 | $11,197 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $11,143 |
| TradjentaLinagliptin | 16 | $10,041 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 28 | $9,423 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $254 | $120,889116 claims |
| Lilly USA, LLCMounjaro, Trulicity | $961 | $114,82799 claims |
| PfizerEliquis | $182 | $86,398107 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $747 | $77,03785 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $343 | $73,81094 claims |
| MerckJanuvia, Belsomra | $154 | $35,02344 claims |
| Novo NordiskOzempic | $171 | $20,52421 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $181 | $11,19717 claims |
| Astellas Pharma US IncMyrbetriq | $161 | $7,74712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Murphysboro
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.